2012
Developing and Validating a Human Laboratory Model to Screen Medications for Smoking Cessation
McKee SA, Weinberger AH, Shi J, Tetrault J, Coppola S. Developing and Validating a Human Laboratory Model to Screen Medications for Smoking Cessation. Nicotine & Tobacco Research 2012, 14: 1362-1371. PMID: 22492085, PMCID: PMC3482010, DOI: 10.1093/ntr/nts090.Peer-Reviewed Original ResearchConceptsSubsequent ad libitum smokingSmoking cessation medicationsAd libitum smokingCessation medicationsNicotine deprivationSmoking cessationNovel smoking cessation medicationsRatings of cravingSmoking lapse behaviorHuman laboratory modelSecondary outcomesClinical efficacyClinical findingsFirst cigaretteMedication effectsSmokingMedication developmentCigarette effectsMedicationsLapse behaviorSmoking lapseTranslational toolScreen medicationsMonetary reinforcementTranslational work
2006
Fatal Factitious Cushing’s Syndrome and Invasive Aspergillosis: Case Report and Review of Literature
Kansagara DL, Tetrault J, Hamill C, Moore C, Olson B. Fatal Factitious Cushing’s Syndrome and Invasive Aspergillosis: Case Report and Review of Literature. Endocrine Practice 2006, 12: 651-655. PMID: 17229661, DOI: 10.4158/ep.12.6.651.Peer-Reviewed Case Reports and Technical NotesConceptsFactitious Cushing's syndromeCushing's syndromeInvasive aspergillosisDiffuse pulmonary infiltratesUntreated Cushing's syndromeFatal septic shockInvasive pulmonary aspergillosisMechanism of immunosuppressionInvasive fungal infectionsHealth care providersReview of literaturePulmonary infiltratesFulminant infectionSeptic shockImmunologic aspectsPulmonary aspergillosisClinical findingsCase reportFatal conditionDifficult diagnosisAdrenal cortexTreatment considerationsFactitious illnessPatient's homeSyndrome